Total Assets
Medtronic Total Assets increased by 0.2% to $91.49B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.7%, from $89.97B to $91.49B. Over 4 years (FY 2021 to FY 2025), Total Assets shows relatively stable performance with a -0.4% CAGR.
Analysis
How to read this metric
An increase suggests business expansion or asset accumulation, while a decrease may indicate asset divestiture or depreciation.
Detailed definition
The aggregate value of all current and non-current assets owned by the company, including cash, inventory, property, pla...
Peer comparison
Varies significantly by industry; medical device peers typically maintain high asset bases due to R&D and manufacturing infrastructure.
total_assetsHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.08B | $91.8B | $91.76B | $91.8B | $90.98B | $89.91B | $93.24B | $94.13B | $90.95B | $90.78B | $90.09B | $90.84B | $89.98B | $89.75B | $90.04B | $89.97B | $91.68B | $90.97B | $91.35B | $91.49B |
| QoQ Change | — | -1.4% | -0.1% | +0.1% | -0.9% | -1.2% | +3.7% | +1.0% | -3.4% | -0.2% | -0.8% | +0.8% | -0.9% | -0.3% | +0.3% | -0.1% | +1.9% | -0.8% | +0.4% | +0.2% |
| YoY Change | — | — | — | — | -2.3% | -2.1% | +1.6% | +2.5% | -0.0% | +1.0% | -3.4% | -3.5% | -1.1% | -1.1% | -0.0% | -1.0% | +1.9% | +1.4% | +1.4% | +1.7% |
Business Segments
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Surgical | — | — | $34.93B | $33.59B | $33.32B | $33.33B | $32.98B | $32.75B |
| Neuroscience | — | — | $18.35B | $18.27B | $18.48B | $18.43B | $18.48B | $18.45B |
| Cardiovascular | $15.03B | $14.49B | $16.04B | $16.13B | $16.55B | $16.57B | $16.66B | $16.75B |
| Diabetes | — | — | $3.93B | $4B | $4.14B | $4.21B | $4.27B | $4.31B |
| Other operating segment | — | — | — | $547M | $296M | $202M | $216M | $207M |
| Total | $93.08B | $90.98B | $90.95B | $89.98B | $91.68B | $90.97B | $91.35B | $91.49B |
Cardiovascular, Diabetes, Medical Surgical, Neuroscience, Other operating segment were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Assets at Other Companies
Frequently Asked Questions
- What is Medtronic's total assets?
- Medtronic (MDT) reported total assets of $91.49B in Q4 2025.
- How has Medtronic's total assets changed year-over-year?
- Medtronic's total assets increased by 1.7% year-over-year, from $89.97B to $91.49B.
- What is the long-term trend for Medtronic's total assets?
- Over 4 years (2021 to 2025), Medtronic's total assets has grown at a -0.4% compound annual growth rate (CAGR), from $93.08B to $91.68B.
- What does total assets mean?
- The total value of everything the company owns.